famotidine has been researched along with Drug-Induced Stevens Johnson Syndrome in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheinfeld, N | 1 |
| Wesson, K | 1 |
| Perry, P | 1 |
| Weinberg, J | 1 |
| Brunner, M | 1 |
| Vardarman, E | 1 |
| Goldermann, R | 1 |
| Goerz, G | 1 |
| Niederau, D | 1 |
| Merk, HF | 1 |
| Scharffetter-Kochanek, K | 1 |
2 other studies available for famotidine and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu | 2003 |
Toxic epidermal necrolysis (Lyell syndrome) following famotidine administration.
Topics: Adult; Famotidine; Histamine H2 Antagonists; Humans; Male; Stevens-Johnson Syndrome | 1995 |